Showing results (301-310 of 5,511) with videos related to

Sort By:
Pageof 552
Circulation Research|September 1, 1980
Acute renovascular hypertension in conscious dogs. Interaction of the renin-angiotensin system and sympathetic nervous system in systemic hemodynamics and regional blood flow responsesH Gavras, C Liang
Applied Optics|October 12, 2010
Effect of antireflection coating on the performance of Faraday rotatorsX Ma, C Liang
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi = Zhonghua Laodong Weisheng Zhiyebing Zazhi = Chinese Journal of Industrial Hygiene and Occupational Diseases|October 15, 2018
[Epidemiological, Occupational Characteristics and Clinical Manifestation of Occupational Forest Encephalitis in HunlunBuir city during 2008-2017]C Liang, W Wei
Leukemia|February 3, 2006
AML patients with CEBPalpha mutations mostly retain identical mutant patterns but frequently change in allelic distribution at relapse: a comparative analysis on paired diagnosis and relapse samplesL-Y Shih, D-C Liang, C-F Huang, et al.
Biopharmaceutics & Drug Disposition|July 1, 1982
Effect of sustained release on the pharmacokinetic profile of indomethacin in manK C Yeh, E T Berger, G O Breault, et al.
Nature Neuroscience|December 7, 2010
Perinatal photoperiod imprints the circadian clockChristopher M Ciarleglio, John C Axley, Benjamin R Strauss, et al.
Postgraduate Medical Journal|January 1, 1987
Clinical experience with flupirtine in the U.SF G McMahon, W F Arndt, J J Newton, et al.
Journal of Clinical Pharmacology|April 1, 1997
Oxaprozin and piroxicam, nonsteroidal antiinflammatory drugs with long half-lives: effect of protein-binding differences on steady-state pharmacokineticsA Karim, R Noveck, F G McMahon, et al.
American Journal of Hypertension|August 1, 1993
Effect of phosphoramidon (endothelin converting enzyme inhibitor) and BQ-123 (endothelin receptor subtype A antagonist) on blood pressure in hypertensive ratsE G McMahon, M A Palomo, M A Brown, et al.
Clinical Pharmacology and Therapeutics|September 1, 1975
Bioavailability of dexamethasone. II. Dexamethasone phosphateL E Hare, K C Yeh, C A Ditzler, et al.
Pageof 552